These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extracellular Vesicles in the Cornea: Insights from Other Tissues. McKay TB; Yeung V; Hutcheon AEK; Guo X; Zieske JD; Ciolino JB Anal Cell Pathol (Amst); 2021; 2021():9983900. PubMed ID: 34336556 [TBL] [Abstract][Full Text] [Related]
3. The corneal fibrosis response to epithelial-stromal injury. Torricelli AA; Santhanam A; Wu J; Singh V; Wilson SE Exp Eye Res; 2016 Jan; 142():110-8. PubMed ID: 26675407 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Extracellular Vesicles for the Treatment of Corneal Injuries and Scars. Deng SX; Dos Santos A; Gee S Transl Vis Sci Technol; 2020 Nov; 9(12):1. PubMed ID: 33200043 [TBL] [Abstract][Full Text] [Related]
5. The role of hepatocyte growth factor in corneal wound healing. Miyagi H; Thomasy SM; Russell P; Murphy CJ Exp Eye Res; 2018 Jan; 166():49-55. PubMed ID: 29024692 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle-Mediated Delivery of miRNA. Shojaati G; Khandaker I; Funderburgh ML; Mann MM; Basu R; Stolz DB; Geary ML; Dos Santos A; Deng SX; Funderburgh JL Stem Cells Transl Med; 2019 Nov; 8(11):1192-1201. PubMed ID: 31290598 [TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles and Cell-Cell Communication in the Cornea. Zieske JD; Hutcheon AEK; Guo X Anat Rec (Hoboken); 2020 Jun; 303(6):1727-1734. PubMed ID: 31136100 [TBL] [Abstract][Full Text] [Related]
8. The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo. Minella AL; Casanova MI; Chokshi TJ; Kang J; Cosert K; Gragg MM; Bowman MA; Mccorkell ME; Daley NL; Leonard BC; Murphy CJ; Raghunathan VK; Thomasy SM Exp Eye Res; 2023 Jan; 226():109338. PubMed ID: 36470430 [TBL] [Abstract][Full Text] [Related]
9. Corneal Opacity: Cell Biological Determinants of the Transition From Transparency to Transient Haze to Scarring Fibrosis, and Resolution, After Injury. Wilson SE; Sampaio LP; Shiju TM; Hilgert GSL; de Oliveira RC Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):22. PubMed ID: 35044454 [TBL] [Abstract][Full Text] [Related]
10. [Corneal wound healing-Pathophysiology and principles]. Brockmann T; Walckling M; Brockmann C; Fuchsluger TMA; Pleyer U Ophthalmologe; 2021 Nov; 118(11):1167-1177. PubMed ID: 34106316 [TBL] [Abstract][Full Text] [Related]
11. The Corneal Basement Membranes and Stromal Fibrosis. Medeiros CS; Marino GK; Santhiago MR; Wilson SE Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4044-4053. PubMed ID: 30098200 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring. Ong HS; Riau AK; Yam GH; Yusoff NZBM; Han EJY; Goh TW; Lai RC; Lim SK; Mehta JS Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108619 [TBL] [Abstract][Full Text] [Related]
13. Utility of nanomedicine targeting scar-forming myofibroblasts to attenuate corneal scarring and haze. Ibrahim Al-Mashahedah AM; Kanwar RK; Kanwar JR Nanomedicine (Lond); 2019 Apr; 14(8):1049-1072. PubMed ID: 30901304 [TBL] [Abstract][Full Text] [Related]